Cellular Bio to buy back $10M in common shares; shares up 24%

|About: Cellular Biomedicine G... (CBMG)|By:, SA News Editor

The board of Cellular Biomedicine (NASDAQ:CBMG) authorizes the repurchase of up to $10M in common stock through open market transactions under its 2017 Stock Repurchase Program.

Update: Shares are up 24% mid-session on double normal volume, albeit on turnover of only 75K.

Subscribe for full text news in your inbox